Revision 1

#8658Store at -20C

1 Kit

(9 x 20 microliters)

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Product Includes Product # Quantity Mol. Wt Isotype/Source
ADAM9 (D64B5) Rabbit mAb 4151 20 µl 100-115, 75-80 kDa Rabbit IgG
DLL1 Antibody 2588 20 µl 82 kDa Rabbit 
DLL3 (G93) Antibody 2483 20 µl 65 kDa Rabbit 
DLL4 Antibody 2589 20 µl 75-80 kDa Rabbit 
Jagged1 (28H8) Rabbit mAb 2620 20 µl 180 kDa Rabbit IgG
Jagged2 (C23D2) Rabbit mAb 2210 20 µl 150 kDa Rabbit IgG
Numb (C29G11) Rabbit mAb 2756 20 µl 72, 74 kDa Rabbit IgG
RBPSUH (D10A4) XP® Rabbit mAb 5313 20 µl 61 kDa Rabbit IgG
TACE (D22H4) Rabbit mAb 6978 20 µl 135 kDa Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl Goat 

Please visit cellsignal.com for individual component applications, species cross-reactivity, dilutions, protocols, and additional product information.

Description

The Notch Receptor Interaction Antibody Sampler Kit provides an economical means to evaluate Notch signaling. The kit contains enough primary antibody to perform two western blots per primary.

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Background

Notch signaling is activated upon engagement of the Notch receptor with its ligands, the Delta, Serrate, Lag2 (DSL) single-pass type I membrane proteins. DSL proteins contain multiple EGF-like repeats and a DSL domain that is required for binding to Notch (1,2). Five DSL proteins have been identified in mammals: Jagged1, Jagged2, Delta-like (DLL) 1, 3, and 4 (3). Ligand binding to the Notch receptor results in two sequential proteolytic cleavages of the receptor by the ADAM protease and the γ-secretase complex. The intracellular domain of Notch is released and then translocates to the nucleus where it activates transcription. Notch ligands may also be processed in a similiar manner, suggesting bi-directional signaling through receptor-ligand interactions (4-6).

TNF-α converting enzyme (TACE), also known as ADAM17, is a transmembrane metalloprotease that plays a key role in the cleavage of a number cell surface molecules in a process known as “shedding". TACE is abundantly expressed in many adult tissues, but in fetal development, expression is differentially regulated (7). TACE activates Notch in a ligand-independent manner and has been shown to play a role in the development of the Drosophila nervous system (8).

Recombining Binding Protein, SUppressor of Hairless (RBPSUH), also termed RBP-J or CSL, is the DNA-binding component of the transcription complex regulated by canonical Notch signaling. In the absence of Notch activation, RBPSUH suppresses target gene expression through interactions with a co-repressor complex containing histone deacetylase. Upon activation of Notch receptors, the Notch intracellular domain (NICD) translocates to the nucleus and binds to RBPSUH. This displaces the co-repressor complex and replaces it with a transcription activation complex that includes Mastermind-like (MAML) proteins and histone acetylase p300, leading to transcriptional activation of Notch target genes (9-11).

Numb contains an amino-terminal phosphotyrosine-binding (PTB) domain and carboxy-terminal endocytic binding motifs for α-adaptin and EH (Eps15 homology) domain-containing proteins, indicating a role in endocytosis (12,13). There are four mammalian Numb splicing isoforms that are differentially expressed and may have distinct functions (14-16). Numb acts as a negative regulator of Notch signaling by promoting ubiquitination and degradation of Notch (17). The protein is asymmetrically segregated into one daughter cell during cell division, producing two daughter cells with different responses to Notch signaling and different cell fates (18,19).

  1. Wilson, A. and Radtke, F. (2006) FEBS Lett 580, 2860-8.
  2. Hansson, E.M. et al. (2004) Semin Cancer Biol 14, 320-8.
  3. Chiba, S. (2006) Stem Cells 24, 2437-47.
  4. Bland, C.E. et al. (2003) J Biol Chem 278, 13607-10.
  5. Six, E. et al. (2003) Proc Natl Acad Sci U S A 100, 7638-43.
  6. LaVoie, M.J. and Selkoe, D.J. (2003) J Biol Chem 278, 34427-37.
  7. Black, R.A. et al. (1997) Nature 385, 729-33.
  8. Delwig, A. and Rand, M.D. (2008) Cell Mol Life Sci 65, 2232-43.
  9. Ehebauer, M. et al. (2006) Sci STKE 2006, cm7.
  10. Borggrefe, T. and Oswald, F. (2009) Cell Mol Life Sci 66, 1631-46.
  11. Kopan, R. and Ilagan, M.X. (2009) Cell 137, 216-33.
  12. Berdnik, D. et al. (2002) Dev Cell 3, 221-31.
  13. Santolini, E. et al. (2000) J Cell Biol 151, 1345-52.
  14. Dho, S.E. et al. (1999) J Biol Chem 274, 33097-104.
  15. Verdi, J.M. et al. (1999) Proc Natl Acad Sci U S A 96, 10472-6.
  16. Verdi, J.M. et al. (1999) Proc Natl Acad Sci U S A 96, 10472-6.
  17. McGill, M.A. and McGlade, C.J. (2003) J Biol Chem 278, 23196-203.
  18. Verdi, J.M. et al. (1996) Curr Biol 6, 1134-45.
  19. Reugels, A.M. et al. (2006) Dev Dyn 235, 934-48.

Background References

    Trademarks and Patents

    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    U.S. Patent No. 7,429,487, foreign equivalents, and child patents deriving therefrom.
    All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

    Limited Uses

    Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

    Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.